Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients
- 6 April 2018
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 50 (3) , 434-441
Abstract
Background Egypt has high incidence of hepatocellular carcinoma (HCC). This is due to wide spread of hepatitis C virus (HCV) infection which is responsible for most of the cases of liver cirrhosis. The major diagnostic techniques for HCC include serum markers and various imaging modalities. Glypican 3 (GPC3) protein is highly expressed in HCC, but not in normal liver tissue. The significance of GPC3 as a predictor or diagnostic tool for human tumors other than HCC is unclear. Aim To quantitatively assess the role of GPC3 in diagnosis of HCC in comparison to α-fetoprotein (AFP), ultrasonography (US), and computerized tomography (CT). Patients and Methods This cross-sectional study enrolled 85 subjects: 40 cirrhotic patients with primary HCC, 30 cirrhotic patients without HCC, and 15 healthy individuals. All patients were recruited from the Gastroenterology and Tropical Departments and outpatient clinics of New Damietta Hospital during the period from November 2010 to August 2012. Results GPC3 is positive in some HCC patients with normal levels of AFP. AFP has lower sensitivity (67.5%) compared to higher sensitivity of GPC3 (82.5%), and near specificity (61.2%) to GPC3 (57.8%). Conclusion and Significance The combined serum AFP and GPC3 significantly increased the sensitivity of HCC diagnosis. Although GPC3 is better than AFP in diagnosis of HCC, it still lacks the 100% sensitivity and specificity because some patients have negative or normal level of GPC3 (below the cutoff point 1.5 ng/ml) despite being diagnosed by triphasic CT.Keywords
This publication has 32 references indexed in Scilit:
- Glypican-3: A new target for cancer immunotherapyEuropean Journal of Cancer, 2011
- Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk AssessmentEnvironmental Health Perspectives, 2010
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Predictors of alpha‐fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a–ribavirin combination therapyJournal of Gastroenterology and Hepatology, 2007
- The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des‐gamma‐carboxy prothrombinJournal of Surgical Oncology, 2007
- How to measure renal function in clinical practiceBMJ, 2006
- Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative studyJournal of Gastroenterology, 2005
- Des-γ-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular CarcinomaJournal of Biological Chemistry, 2005
- Prevalence and epidemiological features of hepatocellular carcinoma in Egypt—a single center experienceHepatology Research, 2001
- Clearance by the hepatic portal circulation of the products of digestion and metabolism in the ruminant gutProceedings of the Nutrition Society, 1974